Christopher J. Sweeney - Publications, H-index & Citations

Christopher J. Sweeney

university of adelaide

86H指数

818论文数

3.0W被引数

收录论文 194

发表时间

Insulin-Like Growth Factor Axis and Survival in Metastatic Hormone-Sensitive Prostate Cancer: Post-Hoc Analysis From the ENZAMET Phase 3 Trial 胰岛素样生长因子轴与转移性激素敏感型前列腺癌的生存：来自ENZAMET III期试验的事后分析

Prostate

IF2.5

2026-09-30

OAAI

Michael A. Cilento; Hui-Ming Lin; Nicole Yeung; Rachel M.N. Kim; Neil Portman; Martin R. Stockler; Andrew J. Martin; Vinod Subhash; Sonia Yip; Lisa M. Butler; Ian C. Marschner; Peter J. Meikle; Arun A. Azad; Ian D. Davis; Lisa G. Horvath; Christopher J. Sweeney

Downregulation of ANPEP Is Associated with Aggressive Prostate Cancer and Poor Disease-specific Outcomes ANPEP的下调与侵袭性前列腺癌及不良疾病特异性预后相关

European Urology Open Science

IF4.5

2025-12-26

OAAI

Ryan M. Putney; Purvish Trivedi; Shivanshu Awasthi; Amparo Serna; Jasreman Dhillon; Christopher J. Sweeney; R. Jeffrey Karnes; Matthew R. Cooperberg; Alejandro Berlin; Paul L. Nguyen; Daniel E. Spratt; Elai Davicioni; James Proudfoot; Monica Ryu; Esther Katende; Jong Y. Park; Timothy R. Rebbeck; Asmaa El-Kenawi; Kosj Yamoah

The Achilles heel of precision AKT-targeted therapies in advanced prostate cancer: therapeutic promise constrained by the test 晚期前列腺癌的精确AKT靶向治疗的致命弱点: 受测试限制的治疗承诺

Annals of Oncology

IF65.4

2025-12-19

PREAI

Emily Grist; Christopher J. Sweeney; Gerhardt Attard

Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer 早期对转移性激素敏感型前列腺癌的 prostate-specific antigen (PSA) 阳性反应预测

Nature Communications

IF15.7

2025-12-17

OAAI

Soumyajit Roy; Yilun Sun; Maha Hussain; Kim N. Chi; Karim Fizazi; Ian D. Davis; Susan Halabi; Neeraj Agarwal; Simon Chowdhury; Bertrand Tombal; Scott C. Morgan; Shawn Malone; Pedro C. Barata; Michael Ong; Christopher J. D. Wallis; Alejandro Berlin; Umang Swami; Amar U. Kishan; Angela Y. Jia; Nicholas G. Zaorsky; Jorge A. Garcia; Prateek Mendiratta; Jason R. Brown; Vinod V. Subhash; Martin R. Stockler; Hayley Thomas; Rana R. McKay; Eric J. Small; Neal D. Shore; Fred Saad; Christopher J. Sweeney; Daniel E. Spratt

Personalized intensification of treatment for hormone-sensitive prostate cancer 激素敏感型前列腺癌的个性化强化治疗

Nature Reviews Clinical Oncology

IF82.2

2025-11-27

PREAI

Michael A. Cilento; Lisa M. Butler; Louise Emmett; Christopher J. Sweeney

A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024 未来晚期前列腺癌临床研究的路线图：2024年晚期前列腺癌共识会议（APCCC）的研究结果

European Journal of Cancer

IF7.1

2025-11-21

PREAI

Ursula M. Vogl; Sara Merler; Antonio Angrisani; Fabio Turco; Ian D. Davis; Jason A. Efstathiou; Karim Fizazi; Nicholas D. James; Neal Shore; Eric J. Small; Matthew R. Smith; Christopher J. Sweeney; Bertrand Tombal; Thomas Zilli; Ken Herrmann; Aurelius Omlin; Silke Gillessen

Target trial emulation of early docetaxel and enzalutamide for metastatic hormone-sensitive prostate cancer 转移性激素敏感性前列腺癌早期多西他赛和恩扎卢amide目标试验模拟

BJU International

IF4.4

2025-11-05

PREAI

Yu Yang Soon; Ian C. Marschner; I. Manjula Schou; Christopher J Sweeney; Ian D. Davis; Martin R. Stockler; Andrew J. Martin

Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers 肿瘤转录组范围表达分类器预测晚期前列腺癌的治疗敏感性

Cell

IF42.5

2025-08-26

OAAI

Emily Grist; Peter Dutey-Magni; Marina A. Parry; Larissa Mendes; Ashwin Sachdeva; James A. Proudfoot; Anis A. Hamid; Mazlina Ismail; Sarah Howlett; Stefanie Friedrich; Lia DePaula Oliveira; Laura Murphy; Christopher Brawley; Oluwademilade Dairo; Sharanpreet Lall; Yang Liu; Daniel Wetterskog; Anna Wingate; Karolina Nowakowska; Leila Zakka; Claire L. Amos; Nafisah B. Atako; Victoria Wang; Hannah L. Rush; Robert J. Jones; Hing Leung; William R. Cross; Silke Gillessen; Chris C. Parker; Teresa Marafioti; Alfonso Urbanucci; Matthew Fittall; Edward M. Schaeffer; Daniel E. Spratt; David Waugh; Thomas Powles; Matthew R. Sydes; Felix Y. Feng; Daniel M. Berney; Mahesh K.B. Parmar; Noel W. Clarke; Elai Davicioni; Tamara L. Lotan; Christopher J. Sweeney; Louise C. Brown; Nicholas D. James; Gerhardt Attard

Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial 局部高危前列腺癌的转录组学分析改善了预后判断，并确定了在NRG肿瘤学/RTOG 0521 III期试验中，将多西他赛添加到根治性放疗联合雄激素抑制治疗中获益。

European Urology Oncology

IF9.3

2025-07-17

OAAI

Ryan M. Phillips; James A. Proudfoot; Elai Davicioni; Yang Liu; Daniel E. Spratt; Jeff M. Simko; Robert B. Den; Alan Pollack; Seth A. Rosenthal; A. Oliver Sartor; Christopher J. Sweeney; Gerhardt Attard; Leslie Longoria; Samir Patel; Michael W. Straza; Jason A. Efstathiou; Amit B. Shah; Karen E. Hoffman; Joseph P. Rodgers; Howard M. Sandler; Felix Y. Feng; Phuoc T. Tran

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab 循环肿瘤DNA监测和接受阿特珠单抗治疗的转移性实体瘤患者的血液肿瘤突变负荷

MOLECULAR ONCOLOGY

IF4.5

2025-05-28

OAAI

Charles Swanton; Russell W. Madison; Candice Francheska B. Tambaoan; Funda Meric-Bernstam; Christopher J. Sweeney; Razelle Kurzrock; Howard A. Burris III; David R. Spigel; Hanna Tukachinsky; Jason Hughes; Julia Malato; Bongin Yoo; Tania Szado; Cheryl Schwab; Lincoln W. Pasquina; Amaya Gasco; Katja Schulze; Claire F. Friedman

Association of the circulating lipid panel, PCPro, with clinical outcomes in metastatic hormone-sensitive prostate cancer: post hoc analysis of the ENZAMET phase III randomised trial (ANZUP 1304)循环脂质面板PCPro与转移性激素敏感前列腺癌临床结局的关联：ENZAMET III期随机试验（ANZUP 1304）的事后分析

Annals of Oncology

IF65.4

2025-05-20

PREAI

H.-M. Lin; T. Scheinberg; N. Portman; R.M.N. Kim; R. Mellor; K. Huynh; A.N. Faulkner; N.A. Mellett; I.D. Davis; A. Martin; D. Sullivan; A. Joshua; M. McJannett; V. Subhash; S. Yip; A.A. Azad; I.C. Marschner; S.A. North; R.S. McDermott; K.N. Chi; M.R. Stockler; C.J. Sweeney; P.J. Meikle; L.G. Horvath

Genetic Drivers of Quality of Life in Prostate Cancer: An Evaluation of Genetic Polymorphisms and Patient-reported Outcomes in the E3805 CHAARTED trial 前列腺癌生命质量的遗传驱动因素：对E3805 CHAARTED试验中遗传多态性和患者报告结局的评估

European Urology Oncology

IF9.3

2025-04-16

PREAI

Daniel Sentana-Lledo; Xiangying Chu; Charles J. Ryan; Arjun Gupta; Christopher J. Sweeney; David F. Jarrard; Elizabeth R. Plimack; Benjamin A. Gartrell; Michael A. Carducci; Maha Hussain; Jorge A. Garcia; David Cella; Robert S. DiPaola; Mark Pomerantz; Alicia K. Morgans

Reply to Felix Melchior, Andreas Pircher, and Isabel Heidegger’s Letter to the Editor re: Johann S. de Bono, Meng He, Chen Shi, et al. Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential150 Trial. Eur Urol. 2025;87:468–75 回复Felix Melchior、Andreas Pircher和Isabel Heidegger致编辑的信：关于Johann S. de Bono、Meng He、Chen Shi等人。第3阶段IPATential150试验中接受Ipatasertib和Abiraterone治疗患者的最终总生存期及与临床结局相关的分子数据。欧洲泌尿外科杂志。2025；87：468–75。

European Urology

IF25.2

2025-04-10

PREAI

Christopher Sweeney; Meng He; Matthew Wongchenko; Roberta Ferraldeschi; Johann S. de Bono

Combination Therapies in Locally Advanced and Metastatic Hormone-sensitive Prostate Cancer 局部晚期和转移性激素敏感性前列腺癌的联合疗法

EUROPEAN UROLOGY

IF25.2

2025-02-01

OAAI

Azad, Arun A.; Kostos, Louise; Agarwal, Neeraj; Attard, Gerhardt; Davis, Ian D.; Dorff, Tanya; Gillessen, Silke; Parker, Chris; Smith, Matthew R.; Sweeney, Christopher J.; Tombal, Bertrand; Fizazi, Karim

Functional versus compositional tests in the risk assessment of the impacts of pesticides on the soil microbiome

ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY

IF2.8

2025-01-10

PREAI

Sweeney, Christopher J.; Bottoms, Melanie; Kaushik, Rishabh; Aderjan, Eva; Sherborne, Neil

Evaluation of clinical risk stratification to determine benefit from long-term versus short-term androgen deprivation in high-risk localized prostate cancer 评估临床风险分层以确定长期与短期雄激素剥夺对高危局限性前列腺癌的益处

PROSTATE CANCER AND PROSTATIC DISEASES

IF5.8

2025-01-08

PREAI

Ravi, Praful; Xie, Wanling; Gillessen, Silke; Tombal, Bertrand; Spratt, Daniel E.; Nguyen, Paul L.; Sweeney, Christopher J.

The influence of soil organic matter content on the toxicity of pesticides to the springtail Folsomia candida

ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY

IF2.8

2025-01-06

PREAI

van Hall, Bart G.; Sweeney, Christopher J.; Bottoms, Melanie; van Gestel, Cornelis A. M.

Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer 寡转移去势敏感性前列腺癌转移导向治疗联合或不联合雄激素阻断治疗的多机构分析

EUROPEAN UROLOGY ONCOLOGY

IF9.3

2024-12-01

OAAI

Deek, Matthew P.; Sutera, Philip; Jing, Yuezhou; Gao, Robert; Rothman, Emily; Day, Heather; Chang, David; Dirix, Piet; Armstrong, Andrew J.; Campbell, Bethany; Campos, Fernando Lopez; Berenguer, Miguel; Ramotar, Matthew; Conde-Moreno, Antonio; Berlin, Alejandro; Bosetti, Davide Giovanni; Corcoran, Niall; Koontz, Bridget; Mercier, Carole; Siva, Shankar; Pryor, David; Ost, Piet; Huynh, Mai Anh; Kroeze, Stephanie; Stish, Bradley; Kiess, Ana; Trock, Bruce; Tran, Phuoc T.; Gillessen, Silke; Sweeney, Christopher

Association of serum steroids with survival in metastatic hormone-sensitive prostate cancer

ENDOCRINE-RELATED CANCER

IF4.6

2024-11-26

PREAI

Mostaghel, Elahe A.; Wang, Victoria; Marck, Brett T.; Sharifi, Nima; Matsumoto, Alvin M.; Sweeney, Christopher J.

Survival of men with metastatic hormone-sensitive prostate cancer and adrenal-permissive HSD3B1 inheritance

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2024-09-17

OAAI

Sharifi, Nima; Diaz, Robert; Lin, Hui-Ming; Roberts, Evan; Horvath, Lisa G.; Martin, Andrew; Stockler, Martin R.; Yip, Sonia; Subhash, Vinod V.; Portman, Neil; Davis, Ian D.; Sweeney, Christopher J.

研究方向